SIRT6 and renal fibrosis: Cai et al. reported that Sirt6 deacetylase histone H3K56 results in decreased β-catenin target gene expression [7], suggesting that the Wnt/β-catenin signaling pathway may be a potential target with therapeutic potential for the treatment of renal fibrosis.